BioTuesdays

Titan’s Probuphine featured on CBS affiliate

Titan Pharmaceuticals

The CBS affiliate in Boston, WBZ-TV, has aired a segment about the opioid crisis, featuring Probuphine, a six-month implant developed by Titan Pharmaceuticals (NASDAQ:TTNP) that releases a steady dose of buprenorphine to provide maintenance treatment for opioid addiction.

WBZ-TV quotes Dr. Genie Bailey of the SStarr Treatment Center in Fall River, MA discussing the benefits of Probuphine and one patient’s dramatic recovery.

The news segment can be viewed here.

POWERED BY

Stay Ahead in Healthcare & Life Sciences